Ergoteles’s Avanos Medical AVNS Stock Holding History

Ergoteles’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,467	Closed	-$757K	–	1049
2023 Q1	$757K	Buy	+25,467	New	+$739K	0.03%	599

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ergoteles's AVNS Position: Q2 2023 in Review

Ergoteles sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 25,467 shares — an estimated $757K sold.

Ergoteles first reported a position in AVNS in Q1 2023 and held it in 1 quarter. The position peaked at $757K in Q1 2023. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

Ergoteles reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 25,467 Avanos Medical shares in Q2 2023, an estimated $757K.
Ergoteles first reported a position in Avanos Medical in Q1 2023 and held it in 1 quarter.
Ergoteles's Avanos Medical position peaked at $757K in Q1 2023.
274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.